Snap-on Incorporated and Rentokil Initial plc: A Detailed Examination of EBITDA Performance

Snap-on vs. Rentokil: A Decade of EBITDA Growth

__timestampRentokil Initial plcSnap-on Incorporated
Wednesday, January 1, 2014410400000767600000
Thursday, January 1, 2015408700000848900000
Friday, January 1, 2016489000000942400000
Sunday, January 1, 2017503200000971900000
Monday, January 1, 20181498000001057400000
Tuesday, January 1, 20195806000001067000000
Wednesday, January 1, 2020581000000991400000
Friday, January 1, 20216560000001249100000
Saturday, January 1, 20227670000001351500000
Sunday, January 1, 202311570000001478800000
Monday, January 1, 20241520700000
Loading chart...

Unleashing insights

A Comparative Analysis of EBITDA Growth: Snap-on vs. Rentokil

In the ever-evolving landscape of global business, understanding the financial health of companies is crucial. This analysis delves into the EBITDA performance of Snap-on Incorporated and Rentokil Initial plc from 2014 to 2023. Over this period, Snap-on consistently outperformed Rentokil, with an average EBITDA nearly double that of Rentokil. Notably, Snap-on's EBITDA grew by approximately 92% from 2014 to 2023, peaking at 1.48 billion in 2023. Meanwhile, Rentokil demonstrated a remarkable growth trajectory, with its EBITDA increasing by nearly 182%, reaching 1.16 billion in 2023. This growth reflects Rentokil's strategic expansions and operational efficiencies. The data highlights the resilience and adaptability of these companies in a competitive market, offering valuable insights for investors and industry analysts alike.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025